glp-1 and pcos for PCOS: Is It the Right Choice? Navigating PCOS: How GLP-1 Medicines
Description
Fueled by the FDAs approval of Wegovy for weight loss in 2021, prescriptions for GLP-1 (glucagon-like peptide-1) drugs rose 587% from 2019 to 2024 as usage expanded beyond diabetes management
Peripherally administered GLP-1 thus indirectly activates neurons of the amygdala
Be aware of early warning signs
Most individuals regain significant weight once these medications are stopped. Of the participants, 21 were using tirzepatide (Mounjaro and Zepbound), and nine were using semaglutide
